Literature DB >> 10099887

Tonsillectomy does not prevent a progressive course in IgA nephropathy.

F M Rasche1, A Schwarz, F Keller.   

Abstract

BACKGROUND: IgA nephropathy, or Berger's disease, is a primary mesangioproliferative glomerulonephritis, usually with a favourable prognosis. PATIENTS AND METHODS: To investigate the effect of tonsillectomy we conducted a retrospective investigation on renal outcome in 55 patients with IgA nephropathy in an outpatient university clinic between 1968 and 1994. Established risk factors for progressive IgA nephropathy were equally distributed in 16 patients subjected to tonsillectomy and in 39 patients without tonsillectomy. Renal survival and impact of risk factors were estimated by Kaplan-Meier analysis and Cox regression model.
RESULTS: Seen in terms of the bivariate Kaplan-Meier analysis the probability of renal survival 10 years after biopsy was 0.37 for the 16 patients with tonsillectomy and 0.63 for the 39 patients without tonsillectomy (log-rank test p = 0.49, not significant). In the multivariate Cox regression model with 6 independent clinical covariates, initially high serum creatinine concentration had the strongest impact on renal outcome (p = 0.002), with a hazard ratio of 8.9 (95% CI: 2.3-35.0). Tonsillectomy had no significant influence in the Cox model (p = 0.37), displaying a hazard ratio of 1.7 (95% CI: 0.5-5.7).
CONCLUSION: In conclusion, tonsillectomy does not reduce the risk of developing renal failure or prevent a progressive course of IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099887

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  24 in total

1.  High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors:  F M Rasche; F Keller; P M Lepper; C Aymanns; W Karges; L-C Sailer; L von Müller; D Czock
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

2.  Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?

Authors:  Luca Vergano; Elisa Loiacono; Roberto Albera; Rosanna Coppo; Roberta Camilla; Licia Peruzzi; Alessandro Amore; Maria Elena Donadio; Federica Chiale; Alberto Boido; Filippo Mariano; Gianna Mazzucco; Sara Ravera; Giovanni Cancarini; Riccardo Magistroni; Giulietta Beltrame; Cristiana Rollino; Piero Stratta; Marco Quaglia; Roberto Bergia; Raffaella Cravero; Stefano Cusinato; Luisa Benozzi; Silvana Savoldi; Carola Licata
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

3.  Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients.

Authors:  Tibor Kovács; Tibor Vas; Csaba P Kövesdy; Péter Degrell; Györgyi Nagy; Zsuzsanna Rékási; István Wittmann; Judit Nagy
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

Review 4.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

5.  Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; T Kahn; J Fahnert
Journal:  Clin Exp Immunol       Date:  2015-11-26       Impact factor: 4.330

6.  Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2016-01-06

Review 7.  Glomerular diseases: emerging tests and therapies for IgA nephropathy.

Authors:  Pietro A Canetta; Krzysztof Kiryluk; Gerald B Appel
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-26       Impact factor: 8.237

8.  Immunoglobulin A nephropathy complicating ulcerative colitis.

Authors:  Aideloje Onime; Emmanuel I Agaba; Yijuan Sun; Robert B Parsons; Karen S Servilla; Larry W Massie; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

9.  Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.

Authors:  Naoto Miura; Hirokazu Imai; Shogo Kikuchi; Shogo Hayashi; Masayuki Endoh; Tetsuya Kawamura; Yasuhiko Tomino; Kumiko Moriwaki; Hideyasu Kiyomoto; Kentaro Kohagura; Eiko Nakazawa; Eiji Kusano; Toshio Mochizuki; Shinsuke Nomura; Tamaki Sasaki; Naoki Kashihara; Jun Soma; Tadashi Tomo; Iwao Nakabayashi; Masaharu Yoshida; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

10.  Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.

Authors:  Hiroyuki Komatsu; Shouichi Fujimoto; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Kazuo Kitamura
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.